|

Daratumumab Injection Clinical Trials

4 actively recruiting trials across 2 locations

Also known as: Darzalex

Other2 trials

FeAsiBility of a Treatment Free Interval in Newly Diagnosed MM Patients Treated With Daratumumab-lenalidomide-dexamethasone (HOVON174MM)
Phase 3
Use of a New Medicine "Daratumumab" to Treat Left-over Cancer in a Blood Cancer Called "T Acute Lymphoblastic Leukemia"
Phase 2

Baltimore, Maryland1 trial

Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders

University of Maryland Greenebaum Comprehensive Cancer Center

Phase 1/2

Boston, Massachusetts1 trial

Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis

Boston Medical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.